Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

102results about How to "Effective prevention and treatment" patented technology

Agonist anti-trk-C monoclonal antibodies

InactiveUS20070036794A1Effective treatment and preventionSuperior propertyNervous disorderGenetic material ingredientsCell systemCellular degeneration
The invention concerns agonist anti-trkC monoclonal antibodies which mimic certain biological activities of NT-3, the native ligand of trkC. The invention further concerns the use of such antibodies in the prevention and / or treatment of cellular degeneration, including nerve cell damage associated with acute nervous cell system injury and chronic neurodegenerative diseases, including peripheral neuropathy.
Owner:GENENTECH INC

Indenone Derivative and Pharmaceutical Composition Comprising Same

An indenone derivative of formula (1) is effective in enhancing the activity of osteoblastic cells and inhibiting bone resorption by osteoclastic cells, and a pharmaceutical composition comprising the indenone derivative or a pharmaceutically acceptable salt thereof is useful for preventing or treating bone diseases such as osteoporosis.
Owner:KOREA RES INST OF CHEM TECH

Veterinary traditional Chinese medicine for preventing and treating fish diseases

The invention relates to a veterinary traditional Chinese medicine for treating fish diseases. The medicine is characterized by comprising the following components in parts by weight: 5-10 parts of folium isatidis, 4-8 parts of coptis chinensis, 6-12 parts of folium cortex eucommiae, 2-6 parts of Chinese Gall, 3-7 parts of acorus calamus, 8-15 parts of gingko leaf, 2-6 parts of pomegranate bark, 4-10 parts of scutellaria baicalensis, 8-15 parts of felwort, 3-8 parts of radix sophorae flavescentis, 6-12 parts of radix bupleuri, 5-10 parts of rheum officinale and 4-9 parts of common andrographis herb. The compound traditional Chinese medicine is synergetic and complementary in medicinal materials, has the effects of resisting bacteria, virus, bacterial endotoxin, fungus and parasite, improving immunity and promoting fish body growth and development, can simultaneously act on multiple targets of multiple diseases of fish, can be used for effectively preventing and treating hemorrhagic disease, septicemia, sepsis and other diseases caused by pathogenic bacterium / or bacterial products (such as bacterial endotoxin), parasite, virus and the like, and has remarkable preventing and treating effects on fish composite infectious diseases caused by multiple infectious agents.
Owner:湖州天健兽药有限公司

Composition for use in the prevention and/or treatment of skin conditions and skin diseases

ActiveUS20190029306A1Effective treatment and preventionPromote skin healthOrganic active ingredientsUnknown materialsPropionateOligosaccharide
The invention discloses a composition comprising oligosaccharide, for use in the prevention and / or treatmentof skin conditions and / or skin diseases by increasing SCFA, in particular colonic propionate and butyrate. Said skin disease is in particular atopic dermatitis.
Owner:SOC DES PROD NESTLE SA

Composition containing beta-glucan for prevention and treatment of osteoporosis

The present invention relates to a composition containing beta-glucan as an effective ingredient for prevention and treatment of osteoporosis. The above captioned beta-glucan is preferably the beta-1.3 / 1.6 glucan having a lactic acid as a substituent and this beta-1.3 / 1.6 glucan is preferably produced from Auerobasidium pullulans SM2001(KCCM 10307).
Owner:GLUCAN

Method of Treating Human Preeclampsia Employing Resibufagenin

A method of treating preeclampsia including administering a therapeutically effective dose of resibufagenin to a patient having preeclampsia. Effecting the determination of the presence of preeclampsia may be by determining whether there has been a substantial elevation in marinobufagenin which may be blood-derived or urine-derived and if such elevation does exist, concluding that preeclampsia does exist. The method may advantageously be practiced by employing urine, blood serum or blood plasma as the body specimen containing the protein in determining whether a patient has preeclampsia. In another embodiment, bufodienolide derivatives other than resibufagenin may be employed in lieu of thereof or in combination therewith. In another embodiment, resibufagenin analogues may be employed in the treatment of preeclampsia.
Owner:PUSCHETT JULES B

Children mouthwash containing cymene bacteriostatic agent and preparation method of children mouthwash

The invention discloses children mouthwash containing a cymene bacteriostatic agent and a preparation method of the children mouthwash. The children mouthwash is prepared from the following materials:a traditional Chinese medicine extract, water, a bacteriostatic agent and sodium chloride, the traditional Chinese medicine extract comprises a caries prevention component, an internal heat clearingand inflammation diminishing component and a tooth strengthening component, the water is deionized water prepared by an RO reverse osmosis method, the bacteriostatic agent is o-cymene-5-ol, based on the total weight of 100%, the mouthwash comprises the following components in percentage by weight: 35% of the traditional Chinese medicine extract, 60% of the water, 4% of the bacteriostatic agent and1% of sodium chloride, the caries prevention component in the traditional Chinese medicine extract comprises green tea, the internal heat clearing and inflammation diminishing component comprises honeysuckle flower, menthae haplocalycis herba, stevia rebaudiana, momordica grosvenori, propolis, aloe and radix rhizoma glycyrrhizae, and the tooth strengthening component comprises alpiniae oxyphyllaefructus, schisandrae chinensis fructus, folium nelumbinis, pericarpium zanthoxyli and angelicae dahuricae radix. The children mouthwash containing the cymene bacteriostatic agent has the effects of clearing internal heat, diminishing inflammation and strengthening teeth, does not have any side effect, and can be used for effectively preventing and treating oral diseases such as dental caries andoral inflammation of children.
Owner:FUJIAN MENGJIAOLAN DAILY CHEM

Biological activity-promoting compositions containing soybean germ-origin isoflavone aglycon

Biological activity-promoting compositions containing soybean germ-origin isoflavone aglycone which promote human or mammalian health and exert effective effects of preventing or treating diseases when absorbed into the body by oral administration, instillation, etc., thereby contributing to the maintenance and promotion of human or mammalian health, prevention of diseases and so on. The biological activity-promoting compositions are characterized by comprising an isoflavone aglycone concentrate which is prepared by fermenting the soybean germ with koji mold to thereby decompose proteins, then hydrolyzing the same and further extracting and concentrating the resultant product with a solvent. The compositions are further characterized in that the content of daidzein amounts is at least 70% by weight based on the isoflavone aglycone in the concentrate.
Owner:NICHIMO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products